Clinical Trials Browser

Adrenoleukodystrophy, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Motor Activity, Neoplasms, Sickle Cell Trait, Leukemia, B-Cell, Leukemia, T-Cell, Leukemia, Myeloid, Acute, beta-Thalassemia

NCT05082519 2023-10-26

IDEAL2

Phase 2 Recruiting

240 enrolled

LymphoidOtherOther hematologic neoplasm

Burkitt Lymphoma, Leukemia, Obesity, Leukemia, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Pediatric Obesity

NCT03899337 2023-01-09

STELLAR

Phase 2 Recruiting

105 enrolled

LymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Leukemia, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT03852407 2022-10-12

HLA

Phase 2 Recruiting

114 enrolled

LymphoidMyeloidOther hematologic neoplasmPlasma cell

Graft vs Host Disease, Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, B-Cell, Hematologic Neoplasms

Clinical Trials

BOOSTER

CLIC-2201 for the Treatment of Relapsed/Refractory B Cell Malignancies

TRICAR-ALL

A Phase I/II Multiple Center Trial of 4SCAR19 Cells in the Treatment of Relapsed and Refractory B Cell Malignancies

Combination CAR-T Cell Therapy Targeting Hematological Malignancies

PIPOZA

CAR2219 CAR-T Cells for the Treatment of R/R B Cell Leukemia and Lymphoma

PRO-SID

CD19-targeted CAR T Cell Autotransfusion for the Treatment of Recurrent/Refractory B-cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma in Children With CD19+

SportTherapy

IDEAL2

STELLAR

HLA